Dabur Limited’s stock experienced a sharp decline with heavy trading volumes on October 19 following its disclosure on October 18 regarding ongoing litigations involving its three US subsidiaries. The litigations are in their early discovery phases and pertain to allegations that a hair-relaxer product may contain chemicals linked to ovarian cancer, uterine cancer, and other health concerns. These cases have been filed in federal and state courts in the US and Canada, with the federal US cases consolidated as a Multi-District Litigation (MDL).
Dabur’s subsidiaries, namely Namaste, Dermoviva, and DINTL, have denied any responsibility and enlisted legal representation to defend themselves against these lawsuits. The defense argument centers on the claim that the allegations rely on an incomplete and unverified study.
For feedback and suggestions, write to us at editorial@iifl.com
Related Tags
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.